1
John G Curd, Lori A Kunkel, Antonio J Grillo Lopez: Treatment of autoimmune diseases. Biogen Idec, Genentech, Sidley Austin, October 26, 2010: US07820161 (61 worldwide citation)

Methods are disclosed of treating rheumatoid arthritis in a human comprising administering to the human more than one intravenous dose of a therapeutically effective amount of rituximab and administering methotrexate to the human.


2
John G Curd, Lori A Kunkel, Antonio J Grillo Lopez: Treatment of Autoimmune Diseases. Genentech, Sidley Austin, January 13, 2011: US20110008250-A1

The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.


3
John G Curd, Lori A Kunkel, Antonio J Grillo Lopez: Treatment of Autoimmune Diseases. Genentech, Sidley Austin, January 13, 2011: US20110008336-A1

The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.


4
John G Curd, Lori A Kunkel, Antonio J Grillo Lopez: Treatment of Autoimmune Diseases. Genetech, Sidley Austin, January 13, 2011: US20110008337-A1

The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.


5
John G Curd, Lori A Kunkel, Antonio J Grillo Lopez: Treatment of Autoimmune Diseases. Genentech, Sidley Austin, January 13, 2011: US20110008338-A1

The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.


6
Antonio J Grillo Lopez, Lori A Kunkel, Mark D Pescovitz: Blocking immune response to a graft. Genentech, Biogen Idec, Sidley Austin, January 7, 2010: US20100003252-A1

The present application describes methods for blocking immune response to foreign antigens in a mammal using antagonists which bind to CD20.


7
John G Curd, Lori A Kunkel, Antonio J Grillo Lopez: Treatment of multiple sclerosis. August 9, 2012: US20120201818-A1

The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.


8
John G Curd, Lori A Kunkel, Antonio J Grillo Lopez: Treatment of auto immune diseases with antagonists which bind to b cell surface markers. Genentech, wu xiaonan, November 6, 2002: CN00809834

The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.


9
Antonio J Grillo Lopez, Lori A Kunkel, Timothy A Stewart: Blocking immune response to foreign antigen using antagonist which binds to cd20. Genentech, wu xiaonan, October 9, 2002: CN00812608

The present application describes methods for blocking immune response to foreign antigens in a mammal using antagonists which bind to CD20.


10